AGM Statement
RNS Number : 7430IAnpario PLC18 June 2026Anpario plc
("Anpario", "Group" or the "Company")
AGM Statement
Anpario plc, the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, is holding its AGM later today at which Matthew Robinson, Chairman, will make the following statement:
"The Group has made a good start to the year with revenue and profit performance ahead of prior year and in line with full year analyst consensus expectations1, despite well-reported geopolitical and related economic conditions.
We are particularly encouraged by a strong trading performance in the Middle-East, including the first sales of our new product, AmpLIPhy. Growth has also continued at pace in the US across both the Bio-Vet and Anpario product ranges, as well as in Australasia.
Following the onset of recent disruptions, the Group initially absorbed increases in logistics costs for goods in transit, but ongoing higher costs have since largely been passed on to our customers in accordance with our terms of trade. We have also experienced some raw material price inflation, particularly in our acid-based eubiotic range, which represents around 20% of sales, for which we have responded in a disciplined manner through targeted price rises. These actions are mitigating the external cost pressures, with gross margins in the first half of the year consistent with the second half of 2025.
The Group was pleased to be recognised with the ESG Company of the Year award at the recent Small Cap Awards, reflecting our continued commitment to sustainability and responsible business practices.
During the period, the Group commenced a share buyback programme, reflecting its strong balance sheet and cash generation, with the Board taking the opportunity to repurchase shares at attractive levels, reflecting its confidence in the Company's future prospects. As at today's date, a total of £2.0m has been expended under the £3.0m buyback programme, with 365,982 shares repurchased. This buy-back is in addition to the bi-annual dividend which in the last year amounted to payments of £2.1m.
Our cash balance was £10.9m as at 31 May 2026 (£12.4m at 31 December 2025), after £1.1m had been expended on the buyback programme at that date, representing a strong financial position from which to continue the profitable development of the business."
The Company's interim results for the six months period ended 30 June 2026 are expected to be announced on 9 September 2026.
1Analyst consensus for FY 2026 immediately prior to this announcement was Revenue of £50.3m, Adj EBITDA of £10.3m and net cash of £16.9m.
Enquiries
Anpario plc
Richard Edwards, Chief Executive Officer
+44(0)7776 417 129
Karen Prior, Corporate Responsibility Director & Company Secretary
+44(0)1909 537 380
Marc Wilson, Group Finance Director
+44(0)1909 537 380
Shore Capital
(Nominated Adviser and Broker)
+44 (0) 20 7408 4090
Stephane Auton
Corporate Advisory
David Coaten
Tom Knibbs
Henry Willcocks
Corporate Broking
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDAGMFFFSIRFIDLIR
Recent news on Anpario
See all newsBrief: Anpario Says Good Start To Year With Revenue & Profit Performance Ahead Of Prior Year
AGM Statement
Posting of Annual Report and Notice of AGM
Brief: Anpario Announces Intention To Commence Share Buyback Programme With Aggregate Value Of Up To £3 Mln
UK's Anpario full-year revenue rises on Bio-Vet acquisition, raises dividend